Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2007
02/07/2007CN1910157A Derivatives of N'- (1,5-diphenyl-1H-pyrazol-3-yl) sulphonamide with CBI receptor affinity
02/07/2007CN1910151A Cyclic amine derivative with heteroaryl ring
02/07/2007CN1910141A Diamino alcohols and their use as renin inhibitors
02/07/2007CN1909909A 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
02/07/2007CN1907984A Compound for preparing intermediate for synthesis of atorvastatin calcium
02/07/2007CN1298715C Non-imidazole compounds as histamine H3 antagonists
02/07/2007CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them
02/06/2007US7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases
02/06/2007US7173128 Benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole derivatives; polymer and photographic stabilizers
02/06/2007US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides
02/06/2007US7173054 Respiratory syncytial virus replication inhibitors
02/06/2007US7173052 Resorcinol for lightening skin removing color
02/06/2007US7173051 Inhibitors of cathepsin S
02/06/2007US7173048 Indolyl derivatives as liver-X-receptor (LXR) modulators
02/06/2007US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands
02/06/2007US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/06/2007US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
02/06/2007US7173035 Arylsulfonamide compounds
02/06/2007US7173034 Drugs for treatment of viral diseases such as Respiratory syncytial virus
02/06/2007US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis
02/06/2007US7173028 Pyrimidine derivatives
02/06/2007US7173027 Provide a physiological effect to a subject
02/06/2007US7173024 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use
02/06/2007US7172907 2-{5-[1-(5-carboxypentyl)-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene]-3-cyano-1,3-pentadienyl}-1,3,3-trimethyl-3H-indolinium (mesocyano Cy5); for sequencing, microarrays, flow cytometry and proteomics
02/01/2007WO2007014290A2 Fungicidal carboxamides
02/01/2007WO2007013830A1 Nitrocatechol derivatives as comt inhibitors
02/01/2007WO2007013694A1 Phenoxyalkanoic acid compound
02/01/2007WO2007012905A1 Colourless water-soluble organic luminophores and intermediates thereof
02/01/2007WO2006000336A9 Anthranilamides serving as pesticides
02/01/2007US20070027321 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
02/01/2007US20070027318 Quinoline derivatives and quinazoline derivatives
02/01/2007US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators
02/01/2007US20070027198 Crystal of heterocyclic compound
02/01/2007US20070027196 Activator of peroxisome proliferator-activated receptor delta
02/01/2007US20070027174 Phenylalanine Enamide Derivatives
02/01/2007US20070027159 Therapeutic agents useful for treating pain
02/01/2007US20070027155 Biaryl piperazinyl-pyridine analogues
02/01/2007US20070027150 2-Amino-quinazolin-5-ones
02/01/2007US20070027149 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors
02/01/2007US20070027148 adrenergic blocking agents such as R-6-Hydroxy-8-{1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylamino]ethyl}-4H-benzo[1,4]oxazin-3-one hydrochloride, used for the treatment of repiratoty system disorders
02/01/2007US20070027147 Biarylurea derivatives
02/01/2007US20070027145 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases
02/01/2007US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
02/01/2007US20070027138 Derivatives and analogs of galanthamine
02/01/2007US20070027135 Apoptosis promoters
02/01/2007CA2616377A1 Nitrocatechol derivatives as comt inhibitors
02/01/2007CA2614288A1 Fungicidal carboxamides
01/2007
01/31/2007EP1748047A1 Pyrazole sulfonylurea compound and herbicide
01/31/2007EP1748045A1 Light-emitting device material and light-emitting device
01/31/2007EP1747217A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
01/31/2007EP1747210A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
01/31/2007EP1747206A1 Amino-tetrazoles analogues and methods of use
01/31/2007EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
01/31/2007EP1746999A1 4-phenylamino-quinazolin-6-yl-amides
01/31/2007EP1746997A2 3-(4-heteroarylcyclohexylamino) czclopentanecarboxamides as modulators of chemokine receptors
01/31/2007EP1746991A2 Daao inhibiting benzisoxazoles for treating mental disorders
01/31/2007EP1746880A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
01/31/2007EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
01/31/2007CN1906191A Preparation method
01/31/2007CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor
01/31/2007CN1906183A N-acylsulfonamide apoptosis promoters
01/31/2007CN1906180A New long acting beta-2-agonists and their use as medicaments
01/31/2007CN1906178A 喹唑啉衍生物 Quinazoline derivatives
01/31/2007CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
01/31/2007CN1906171A Substituted azole compounds, preparation and application thereof
01/31/2007CN1906167A Novel pyridine derivative and pyrimidine derivative (2)
01/31/2007CN1906166A Novel pyridine derivative and pyrimidine derivative (1)
01/31/2007CN1906165A Novel herbicides
01/31/2007CN1905873A Bicyclic inhibitors of MEK and methods of use thereof
01/31/2007CN1905872A Amino substituted pyridinyl methanone compounds useful in treating kinase disorders
01/31/2007CN1905869A Indolinone based protein kinase inhibitors
01/31/2007CN1905868A DPP-IV inhibitors
01/31/2007CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
01/30/2007US7169951 Quinazoline derivatives and pharmaceutical applications thereof
01/30/2007US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
01/30/2007US7169805 Captopril derivatives
01/30/2007US7169803 For therapy of disorders which are responsive to the opening of potassium channels, for therapy of ischemia, stroke, convulsions, epilepsy, asthma, irritable bowel syndrome, migraine, traumatic brain injury, elevated intracranial pressure, spinal cord injury, carbon monoxide poisoning, sexual dysfunction
01/30/2007US7169801 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion
01/30/2007US7169800 For cancer therapy
01/30/2007US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases
01/30/2007US7169797 Protein-tyrosine phosphatase inhibitors and uses thereof
01/30/2007US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders
01/30/2007US7169789 Quinoline derivatives and quinazoline derivatives
01/30/2007US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
01/30/2007US7169784 Medical devices employing triazine compounds and compositions thereof
01/30/2007US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
01/30/2007US7169777 Melanocortin receptor agonists
01/30/2007CA2350573C Piperidines as ccr5 modulators
01/30/2007CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy
01/30/2007CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
01/30/2007CA2214322C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
01/30/2007CA2207628C 3-aryl-1,2,4-triazole derivatives with herbicidal properties
01/25/2007WO2007011721A1 Inhibitors of mitotic kinesin
01/25/2007WO2007011623A1 Quinazoline derivatives useful in cancer treatment
01/25/2007WO2007011618A1 Quinazoline derivatives useful in cancer treatment
01/25/2007WO2007010383A1 Novel heterocyclidene acetamide derivative
01/25/2007WO2007010235A1 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide
01/25/2007WO2007010144A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof
01/25/2007WO2007009906A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists